Abstract
The effects of dizocilpine (MK-801), (±)-5-methyl-10,11-dihydro-5Hdibenzo-[a,d]-cyclohepten-5,10-imine maleate, after IP injection into freely behaving rats, have been compared with the action of ketamine-chloride and phencyclidine (PCP). MK-801 produced strongly dose-dependent effects which could be followed quantitatively over a time of 4 h. During this time spectral analysis of the field potentials continuously recorded from frontal cortex, hippocampus, striatum, and reticular formation revealed a particular pattern of changes which was very stable over time, and, after low doses of 0.05 and 0.1 mg/kg, matched that produced by phencyclidine (2 and 4 mg/kg) or ketamine chloride (10 and 20 mg/kg). With higher doses of MK-801 a continuous change from power decreases to power increases was observed. These increases were accompanied by strong behavioral effects in terms of impaired locomotor control. All three non-competitive NMDA antagonists showed a high degree of similarity with respect to the changes of the frequency content of the field potentials over time. The same pattern of electrical changes could be observed after the application ofl-dopa (50 mg/kg) or amphetamine (0.2 mg/kg). This can be interpreted in the sense that the same population of cells within the recording area which is under dopaminergic control is at the same time under glutamate control. This leads to the hypothesis that it might be possible to bypass the missing dopaminergic control during parkinsonism by noncompetitive NMDA-receptor blocking drugs.
Similar content being viewed by others
References
Ahrends H, Läuter J (1974) Mehrdimensionale Varianzanalyse. Akademieverlag, Berlin
Ashton D, Willems R, De Prins E, Wauquier A (1988) Selective inhibition of synaptic versus non-synaptic epileptogenesis by NMDA antagonists in the in vitro hippocampus. Epilepsy Res 2:219–222
Bormann J (1989) Memantine is a potent blocker of N-methyl-d-aspartate (NMDA) receptor channels. Eur J Pharmacol 166:591–592
Bourne GW, Esplin B, Capek R (1988) Disinhibitory effect of phencyclidine in the hippocampus in vitro: PCP receptors implicated. Eur J Pharmacol 150:67–74
Clineschmidt BV, Martin GE, Bunting PR (1982) Anticonvulsant activity of (±)-5-methyl-10,11-dihydro-5Hdibenzo-[a,d]-cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug Dev Res 2:123–134
Dimpfel W, Spüler M, Nickel B (1986) Radioelectroencephalography (Tele-Stereo-EEG) in the rat as a pharmacological model to differentiate the central action of flupirtine from that of opiates, diazepam and phenobarbital. Neuropsychobiology 16:163–168
Dimpfel W, Spüler M, Koch R, Schatton W (1987) Radioelectroencephalographic comparison of memantine with receptor-specific drugs acting on dopaminergic transmission in freely moving rats. Neuropsychobiology 18:212–218
Dimpfel W, Spüler M, Borbe HO (1988) Monitoring of the effects of antidepressant drugs in the freely moving rat by radioelectroencephalography (Tele-Stereo-EEG). Neuropsychobiology 19:116–120
Dimpfel W, Spüler M, Menge HG (1989a) Effects of the antiparkinson drug budipine on EEG activity in unrestrained rats. Arzneimittelforschung 39:560–563
Dimpfel W, Spüler M, Nichols DE (1989b) Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG). Psychopharmacology 98:297
Gean P-W, Shinnick-Gallagher P (1988) Epileptiform activity induced by magnesium-free solution in slices of rat amygdala: antagonism by N-methyl-d-aspartate receptor antagonists. Neuropharmacology 27:557–562
Iversen LL, Woodruff GN, Kemp JA, Foster AC, Gill R, Wong EHF (1988a) Pharmacology and neuroprotective effects of the NMDA antagonist MK-801. In: Domino EF, Kamenka J-D (eds) Sigma and phencyclidine-like compounds as molecular probes in biology. NPP Books, Ann Arbor, MI, p 757
Iversen LL, Woodruff GN, Kemp JA, Foster AC, Gill R, Wong EHF (1988b) Neuroprotective properties of the glutamate antagonist dizocilpine maleate (MK-801) in animal models of focal and global ischaemia. In: Krieglstein J (ed) Pharmacology of cerebral ischaemia. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, pp 165–171
Klockgether T, Turski L (1989) Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease. Trends Neurosci 12:285–286
Koek W, Woods JH, Winger GD (1988) MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther 245:969–974
Lodge D, Aram JA, Church J, Davies SN, Martin D, O'Saughnessy CT, Zeman S (1987) Excitatory amino acids and phencyclidine-like drugs. In: Hicks TP, Lodge D, McLellan H (eds) Excitatory amino acid transmission. Liss, New York, pp 83–90
Nehls DG, Kurumaji A, Park CK, McCulloch J (1988) Differential effects of competitive and non-competitiveN-methyl-d-aspartate antagonists on glucose use in the limbic system. Neurosci Lett 91:204–210
Olney JW, Price MT, Labruyere J, Salles KS, Frierich G, Mueller M, Silverman E (1987) Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists. Eur J Pharmacol 142:319–320
Paxinos G, Watson C (1982) The rat brain in stereotactic coordinates. Academic Press, New York
Piercey MF, Hoffmann WE, Kaczkofsky P (1988) Functional evidence for PCP-like effects of the anti-stroke candidate MK-801. Psychopharmacology 96:561–562
Price GW, Ahier RG, Middlemiss DN, Singh L, Tricklebank MD, Wong EHF (1988) In vivo labelling of the NMDA receptor channel complex by [3H]MK-801. Eur J Pharmacol 158:279–282
Raffa RB, Ortegòn ME, Robisch DM, Martin GE (1989) In vivo demonstration of the enhancement of MK-801 byl-glutamate. Life Sci 44:1593–1599
Schmidt WJ, Bubser M (1989) Anti-cataleptic effects of theN-methyl-d-aspartate antagonist MK-801 in rats. Pharmacol Biochem Behav 32:621–623
Speckmann E-J, Caspers H, Elger CE (1984) Neuronal mechanisms underlying the generation of field potentials. In: Elbert T, Rockstroh B, Lutzenberger W, Birbaumer N (eds) Self regulation of the brain and behavior. Springer, Berlin Heidelberg New York
Taylor DP, Behling SH (1989) Phencyclidine acts as anN-methyl-d-aspartate agonist in vitro. Drug Dev Res 17:63–70
Wong EHF, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL (1986) The anticonvulsant MK-801 is a potentn-methyl-d-aspartate antagonist. Proc Natl Acad Sci USA 83:7104–7108
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dimpfel, W., Spüler, M. Dizocilpine (MK-801), ketamine and phencyclidine: low doses affect brain field potentials in the freely moving rat in the same way as activation of dopaminergic transmission. Psychopharmacology 101, 317–323 (1990). https://doi.org/10.1007/BF02244048
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244048